𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers

✍ Scribed by Kosei Ito


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
417 KB
Volume
112
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF‐β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a gatekeeper linking oncogenic Wnt and anti‐oncogenic TGF‐β/BMPs signaling pathways in intestinal tumorigenesis in mouse and human. Also, loss of RUNX3 leading to elevated oncogenic Wnt activity was found to be a key event in inducing a precancerous state of the stomach. Chronic Helicobacter pylori infection is reported to inactivate RUNX3 in gastric carcinogenesis by multiple mechanisms. This “Prospect” focuses on our current understanding of the tumor suppressive functions of RUNX3 in the context of gastrointestinal cancer initiation and progression. J. Cell. Biochem. 112: 1243–1249, 2011. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Oncogenic role of RUNX3 in head and neck
✍ Dr. Yasusei Kudo; Takaaki Tsunematsu; Takashi Takata 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract Cumulative evidences show that Runt‐related transcription factor 3 (RUNX3) has a tumor suppressive role in various cancers. In particular, RUNX3 appears to be an important component of the transforming growth factor‐β (TGF‐β)‐induced tumor suppression pathway. Contrary to reports on thi

Protein kinase Cι expression and oncogen
✍ Nicole R. Murray; Krishna R. Kalari; Alan P. Fields 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

## Abstract Accumulating evidence demonstrates that PKCι is an oncogene and prognostic marker that is frequently targeted for genetic alteration in many major forms of human cancer. Functional data demonstrate that PKCι is required for the transformed phenotype of lung, pancreatic, ovarian, prostat

Transcription factors and recessive onco
✍ John D. Minna; Jochen Schütte; Jean Viallet; François Thomas; Frederic J. Kaye; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 421 KB

Expression of the jun family of transcription factorslproto-oncogenes in lung cancer From recent studies it is now clear that the product of the cellular counterpart of the oncogene jun (Maki et al., 1987) is one of the proteins making up the transcription-factor preparation AP-1 (Angel et al., 198